Company intelligence / Profile preview

Amnol

Novara, Piedmont, Italy
Ownership
Private
Employees
~35
Development stage
Other
01

Overview

Amnol is an Italian pharmaceutical company specializing in the development and commercialization of nutraceuticals, medical devices, and dermocosmetics. Founded in 1978 and based in Novara, the company focuses on therapeutic areas such as angiology, proctology, orthopedics, and dermatology. Amnol's product portfolio, which includes well-known brands like Venoplant and Artrosulfur, is designed to provide evidence-based solutions for vascular health, joint care, and skin disorders. The company maintains a strong presence in the Italian market through a dedicated network of medical representatives and a commitment to scientific research. Amnol continues to expand its offerings by integrating high-quality ingredients with innovative delivery systems to improve patient well-being.

Therapeutic areas
CardiovascularDermatologyRheumatologyGastroenterologyOphthalmology
Modalities
Small moleculeMedical device
Industry
Biotech
02

Drug pipeline

2 assets

Flebonorm H

Unknown

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Amnol.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amnol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call